Working with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.
Kayla Freeman, DNP, APRN, FNP-C
Advertisement
Articles by Kayla Freeman, DNP, APRN, FNP-C
Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Advertisement
Latest Updated Articles
Oncology Drug Crash Course: Olaparib (Lynparza)Published: October 24th 2022 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
2
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
3
NGS Streamlines Biomarker Testing in Solid Tumors
4
Solo Sevabertinib Shows Durable Activity in HER2+ NSCLC
5
